- call +1-201-465-4211
- email sales@mrinsights.biz
Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eventually everyday activities, such as walking or getting dressed, become difficult .Chronic bronchitis and emphysema are older terms used for different types of COPD.
Scope of the Report:
This report studies the Chronic Obstructive Pulmonary Disease market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Chronic Obstructive Pulmonary Disease market by product type and applications/end industries.
Globally the market for COPD is increasing rapidly. The major factor that derives the growth of COPD is the increasing growth in smoking in adults. Furthermore increasing pollution in the environment and increasing asthma patients are increasing the growth of COPD market.
The global Chronic Obstructive Pulmonary Disease market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Chronic Obstructive Pulmonary Disease.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
AstraZeneca
GSK
MSD
Sunovion
Novartis
Roche Group
Pfizer
Jubilant Pharma Limited
Almirall
Horizon Pharma
Boehringer Ingelheim
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Bronchodilators
Glucocorticoids
Other
Market Segment by Applications, can be divided into
Prevention
Diagnostic
Treatment
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Chronic Obstructive Pulmonary Disease Market Overview
1.1 Product Overview and Scope of Chronic Obstructive Pulmonary Disease
1.2 Classification of Chronic Obstructive Pulmonary Disease by Types
1.2.1 Global Chronic Obstructive Pulmonary Disease Revenue Comparison by Types (2017-2023)
1.2.2 Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Types in 2017
1.2.3 Bronchodilators
1.2.4 Glucocorticoids
1.2.5 Other
1.3 Global Chronic Obstructive Pulmonary Disease Market by Application
1.3.1 Global Chronic Obstructive Pulmonary Disease Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Prevention
1.3.3 Diagnostic
1.3.4 Treatment
1.4 Global Chronic Obstructive Pulmonary Disease Market by Regions
1.4.1 Global Chronic Obstructive Pulmonary Disease Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Chronic Obstructive Pulmonary Disease Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Chronic Obstructive Pulmonary Disease Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Chronic Obstructive Pulmonary Disease Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Chronic Obstructive Pulmonary Disease Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Chronic Obstructive Pulmonary Disease Status and Prospect (2013-2023)
1.5 Global Market Size of Chronic Obstructive Pulmonary Disease (2013-2023)
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.2 GSK
2.2.1 Business Overview
2.2.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GSK Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.3 MSD
2.3.1 Business Overview
2.3.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 MSD Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sunovion
2.4.1 Business Overview
2.4.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sunovion Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novartis
2.5.1 Business Overview
2.5.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.6 Roche Group
2.6.1 Business Overview
2.6.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Roche Group Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.8 Jubilant Pharma Limited
2.8.1 Business Overview
2.8.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.9 Almirall
2.9.1 Business Overview
2.9.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Almirall Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.10 Horizon Pharma
2.10.1 Business Overview
2.10.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Horizon Pharma Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.11 Boehringer Ingelheim
2.11.1 Business Overview
2.11.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
3 Global Chronic Obstructive Pulmonary Disease Market Competition, by Players
3.1 Global Chronic Obstructive Pulmonary Disease Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Chronic Obstructive Pulmonary Disease Players Market Share
3.2.2 Top 10 Chronic Obstructive Pulmonary Disease Players Market Share
3.3 Market Competition Trend
4 Global Chronic Obstructive Pulmonary Disease Market Size by Regions
4.1 Global Chronic Obstructive Pulmonary Disease Revenue and Market Share by Regions
4.2 North America Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
4.3 Europe Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
4.5 South America Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
5 North America Chronic Obstructive Pulmonary Disease Revenue by Countries
5.1 North America Chronic Obstructive Pulmonary Disease Revenue by Countries (2013-2018)
5.2 USA Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
5.3 Canada Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
5.4 Mexico Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
6 Europe Chronic Obstructive Pulmonary Disease Revenue by Countries
6.1 Europe Chronic Obstructive Pulmonary Disease Revenue by Countries (2013-2018)
6.2 Germany Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
6.3 UK Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
6.4 France Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
6.5 Russia Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
6.6 Italy Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Chronic Obstructive Pulmonary Disease Revenue by Countries
7.1 Asia-Pacific Chronic Obstructive Pulmonary Disease Revenue by Countries (2013-2018)
7.2 China Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
7.3 Japan Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
7.4 Korea Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
7.5 India Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
8 South America Chronic Obstructive Pulmonary Disease Revenue by Countries
8.1 South America Chronic Obstructive Pulmonary Disease Revenue by Countries (2013-2018)
8.2 Brazil Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
8.3 Argentina Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
8.4 Colombia Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Chronic Obstructive Pulmonary Disease by Countries
9.1 Middle East and Africa Chronic Obstructive Pulmonary Disease Revenue by Countries (2013-2018)
9.2 Saudi Arabia Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
9.3 UAE Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
9.4 Egypt Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
9.5 Nigeria Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
9.6 South Africa Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
10 Global Chronic Obstructive Pulmonary Disease Market Segment by Type
10.1 Global Chronic Obstructive Pulmonary Disease Revenue and Market Share by Type (2013-2018)
10.2 Global Chronic Obstructive Pulmonary Disease Market Forecast by Type (2018-2023)
10.3 Bronchodilators Revenue Growth Rate (2013-2023)
10.4 Glucocorticoids Revenue Growth Rate (2013-2023)
10.5 Other Revenue Growth Rate (2013-2023)
11 Global Chronic Obstructive Pulmonary Disease Market Segment by Application
11.1 Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Application (2013-2018)
11.2 Chronic Obstructive Pulmonary Disease Market Forecast by Application (2018-2023)
11.3 Prevention Revenue Growth (2013-2018)
11.4 Diagnostic Revenue Growth (2013-2018)
11.5 Treatment Revenue Growth (2013-2018)
12 Global Chronic Obstructive Pulmonary Disease Market Size Forecast (2018-2023)
12.1 Global Chronic Obstructive Pulmonary Disease Market Size Forecast (2018-2023)
12.2 Global Chronic Obstructive Pulmonary Disease Market Forecast by Regions (2018-2023)
12.3 North America Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
12.4 Europe Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
12.6 South America Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Chronic Obstructive Pulmonary Disease Picture
Table Product Specifications of Chronic Obstructive Pulmonary Disease
Table Global Chronic Obstructive Pulmonary Diseas
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
